Physiological properties of penicillin-binding proteins in group A streptococci.

Antimicrobial Agents and Chemotherapy
L GutmannA Tomasz

Abstract

We detected five major penicillin-binding proteins (PBPs) in group A streptococci by labeling either cell membrane preparations or live bacteria with tritiated penicillin. All PBPs appeared to be equally accessible to penicillin in vitro and in vivo. Individual PBPs differed in their rates of deacylation, and four of the five PBPs underwent rapid inactivation both in vivo and in vitro. At least two processes seemed to contribute to in vivo inactivation; these were (i) a penicillin-induced release of all five PBPs into the growth medium and (ii) degradation, as evidenced by the appearance of penicillin-labeled protein band of lower molecular weight and also by a gradual increase in material migrating with the same electrophoretic mobility as PBP 3. Inactivation of the PBPs was stimulated greatly by pretreatment of bacteria with gentamicin, cerulenin, or Triton X-100, whereas chloramphenicol, tetracycline, and lincomycin treatments had no such effect.

References

Jun 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·C E Buchanan, J L Strominger
May 1, 1977·Antimicrobial Agents and Chemotherapy·D Horne, A Tomasz
Nov 15, 1973·Journal of Molecular Biology·U K Laemmli, M Favre
Jul 1, 1974·European Journal of Biochemistry·W M Bonner, R A Laskey
May 1, 1971·The Journal of Experimental Medicine·V A FischettiA W Bernheimer
May 16, 1980·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·J M GhuysenM Nieto
Sep 1, 1980·European Journal of Biochemistry·J CoyetteR Fontana

❮ Previous
Next ❯

Citations

Jul 1, 1995·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·A Tomasz, R Munoz
Feb 1, 1982·Antimicrobial Agents and Chemotherapy·A J Godfrey, L E Bryan
Jul 1, 1982·Antimicrobial Agents and Chemotherapy·L Gutmann, A Tomasz
Jul 1, 1985·Antimicrobial Agents and Chemotherapy·C ThauvinR C Moellering
Sep 1, 1990·Antimicrobial Agents and Chemotherapy·J PierreL Gutmann
Apr 20, 2012·Molecular Microbiology·Assaf RazVincent A Fischetti
Apr 4, 2014·Clinical Microbiology Reviews·Mark J WalkerVictor Nizet
Aug 10, 2017·Molecular Microbiology·Jad SassineRichard A Daniel

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.